Who
Robert Arthur Harrington
Director
Company insider
Files Form 4 as: Director, Cytokinetics.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $395K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Apr 2022
- Last trade
- 16 Oct 2026
- Last filed
- 20 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 20 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K195 at $63.92 | filing |
| 15 Jul 2026filed 16 Jul 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K151 at $82.62 | filing |
| 15 Jul 2026filed 16 Jul 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K151 at $82.62 | filing |
| 27 May 2026filed 27 May 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | —2,851 at $0.00 | filing |
| 27 May 2026filed 27 May 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,301 at $0.00 | filing |
| 27 May 2026filed 27 May 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,301 at $0.00 | filing |
| 27 May 2026filed 27 May 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | —2,851 at $0.00 | filing |
| 15 Apr 2026filed 15 Apr 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K191 at $65.37 | filing |
| 15 Apr 2026filed 15 Apr 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K191 at $65.37 | filing |
| 15 Jan 2026filed 16 Jan 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K197 at $63.44 | filing |
| 15 Jan 2026filed 16 Jan 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K197 at $63.44 | filing |
| 1 Dec 2025filed 2 Dec 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $144K2,150 at $66.80 | filing |
| 15 Oct 2025filed 16 Oct 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K199 at $62.80 | filing |
| 2 Sep 2025filed 2 Sep 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $105K2,150 at $48.67 | filing |
| 15 Jul 2025filed 16 Jul 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K328 at $38.01 | filing |
| 14 May 2025filed 19 May 2025 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,880 at $0.00 | filing |
| 14 May 2025filed 19 May 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | —7,333 at $0.00 | filing |
| 15 Apr 2025filed 16 Apr 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code A | $12K324 at $38.56 | filing |
| 3 Apr 2025filed 4 Apr 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $18K450 at $39.43 | filing |
| 4 Mar 2025filed 4 Mar 2025 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $38K900 at $42.50 | filing |
News
Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) vs. Cytokinetics (NASDAQ:CYTK)CYTK · dailypolitical.com · 18 Oct 2026Head to Head Comparison: Cytokinetics (NASDAQ:CYTK) vs. Pluri (NASDAQ:PLUR)CYTK · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Robert Arthur Harrington; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.